Poland – Research and experimental development services – Świadczenie usług polegających na wykonaniu zadań powierzonych przez Sponsora związanych z realizacją niekomercyjnego badania klinicznego (NEFRYT) w dwóch ośrodkach – Instytutu Matki i Dziecka oraz Państwowego Instytutu Medycznego Ministerstwa Spraw Wewnętrznych i Administracji, wraz z przygotowaniem, konfiguracją, udostępnieniem systemu Elektronicznej Karty Obserwacji Klinicznej eCRF (...)
Opportunity Score
Confidence: 40%
Complexity: high
7 days
Deadline
services
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
Open tender from Instytut Matki i Dziecka (Warsaw, Poland) for comprehensive clinical trial supervision services (non-commercial NEFRYT study) across two centers, including eCRF system with IWRS module. Single lot, no partial bids. Strict eligibility requiring specific experience in non-commercial CRO studies, HIS integration, and eCRF deployment. Award: 60% price, 40% quality. No estimated value disclosed. Deadline: 2026-06-22.
Strengths
Documents available
Open procedure
7 days left
Risks
Submission deadline in 7 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Eligibility criteria: Proven experience in at least 2 non-commercial multi-center clinical trials in CRO function completed recruitment as per initial funding plan.
- At least 1 service for developing and implementing dedicated IT systems integrated with HIS (including descriptive data, procedures, lab results, imaging, medications, dates).
- At least 1 service for developing and implementing eCRF system integrated with HIS.
Buyer
Name
Instytut Matki i Dziecka
Location
Warszawa, POL
Website
Buyer profile
Identifier
NIP: 525-00-08-471
Lots (3)
Single lot covering clinical trial supervision (CRO function) for a non-commercial phase III study (NEFRYT) comparing pregabalin, sacral neuromodulation, and implantable tibial nerve stimulation for refractory overactive bladder. Includes eCRF and IWRS system development, integration with HIS, and maintenance. Performance in two Warsaw centers.
Additional CPV classification (72000000 - IT services) for the same contract. No further details provided.
Additional CPV classification (72212517 - Software development services) for the same contract. No further details provided.
Procurement Details
Publication
21 May 2026
Deadline
22 Jun 2026, 07:00
Procedure
open
Contract
services
Language
POL
Publication #
353045-2026
Classification
Performance: Poland
Documents (2)
Opportunity Score
Confidence: 40%
Complexity: high
7 days
Deadline
services
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation